TITLE

ARE YOU MAN ENOUGH?

PUB. DATE
April 2000
SOURCE
Time International (South Pacific Edition);4/24/2000, Issue 16, p56
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Discusses testosterone therapy, including the physiological effects of testosterone and how it is commonly administered. Introduction of a testosterone gel, Unimed Pharmaceuticals' AndroGel in the United States in the summer of 2000; Dangers of testosterone supplementation; Controversy over the phenomenon of so-called male menopause; Social implications of testosterone levels including a change of ideals regarding the male physique.
ACCESSION #
3016351

 

Related Articles

  • ARE YOU MAN ENOUGH? Lacayo, Richard; McLaughlin, Lisa; Park, Alice // Time;4/24/2000, Vol. 155 Issue 16, p58 

    Discusses testosterone therapy, including the physiological effects of testosterone and how it is commonly administered. Introduction of a testosterone gel, Unimed Pharmaceuticals' AndroGel in the United States in the summer of 2000; Dangers of testosterone supplementation; Controversy over the...

  • Long-term effects of intermittent androgen suppression therapy on lean and fat mass: a 33-month prospective study. Spry, N A; Taaffe, D R; England, P J; Judge, J S; Stephens, D A; Peddle-McIntyre, C; Baker, M K; Newton, R U; Galvão, D A // Prostate Cancer & Prostatic Diseases;Mar2013, Vol. 16 Issue 1, p67 

    Background:To examine changes to whole body and regional lean mass (LM) and fat mass (FM) over 33 months of intermittent androgen suppression therapy (IAST).Methods:Phase II cohort study of 72 prostate cancer patients without metastatic bone disease. Patients received flutamide 250 mg tid and...

  • Underarm Testosterone Product Approved as Replacement Therapy. SCHIESZER, JOHN // Renal & Urology News;Aug2011, Vol. 10 Issue 8, p14 

    The article reports that the U.S. Food and Drug Administration (FDA) has approved the underarm applicator formulation of Axiron (testosterone) topical solution CIII as androgen replacement therapy in males with a deficiency or absence of endogenous testosterone.

  • Testosterone Slow To Recover After ADT. SCHIESZER, JOHN // Renal & Urology News;Jul2013, Vol. 12 Issue 7, p21 

    The article focuses on studies regarding patients with prostate cancer (PCa) treated with androgen deprivation therapy (ADT), which revealed that testosterone levels take a long time to recover after discontinuation of ADT.

  • Priapism Risk Minimal with AndroGel 1%.  // Renal & Urology News;Mar2013, Vol. 12 Issue 3, p27 

    The article reports on a study which suggests that the testosterone replacement with one percent testosterone gel (AndroGel 1%) is rarely associated with the development of priapism.

  • The pause that depresses.  // Joe Weider's Muscle & Fitness;Sep95, Vol. 56 Issue 9, p46 

    Examines the female version of the menopause called andropause of viropause in males. Remarks on libido production; Effect of testosterone replacement.

  • Do men go through `menopause,' too?  // Mayo Clinic Health Letter;Oct1999, Vol. 17 Issue 10, Medical Essay p3 

    Looks at the issue of whether men experience menopause. Testosterone levels in older men; Variance in the rate of testosterone decline among individual men; Signs and symptoms of decreased testosterone.

  • Recognize and treat male menopause.  // South Asian Post;7/14/2011, p10 

    The article reports that middle age men cope with biological changes called the male menopause which is caused by a gradual decline in testosterone with symptoms similar to depression that triggers mood swings, lethargy, and low sex drive.

  • HORMONES FOR MEN. Groopman, Jerome // New Yorker;7/29/2002, Vol. 78 Issue 21, p34 

    Reports the launch of public-awareness campaign to help recognize the symptoms of andropause in the U.S. Decline on testosterone level; Details on the forms of testosterone-replacement therapy for men; Emphasis on the increasing intimacy between commercial and clinical concerns.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics